-

SHAREHOLDER ALERT: Robbins LLP Reminds Investors of Class Action Against Redwire Corporation (RDW) f/k/a Genesis Park Acquisition Corp.

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased Redwire Corporation (NYSE: RDW) between August 11, 2021 and November 14, 2021. The complaint alleges violations of the Securities Exchange Act of 1934. Redwire purports to offer mission critical space solutions and high reliability components for the next generation space economy.

If you suffered a loss due to Redwire Corporation's misconduct, click here.

There Were Material Weaknesses in Redwire Corporation's (RDW) Internal Controls Over Financial Reporting

According to the complaint, Genesis Park Acquisition Corp., a special purpose acquisition company, combined with certain entities to become Redwire on September 2, 2021. On November 10, 2021, Redwire announced it would postpone the release of its third quarter earnings results. The Company "was notified by an employee of potential accounting issues at a business subunit," and the Audit Committee was investigating the allegations. On this news, Redwire's stock price fell $1.92, or 16%, to close at $9.99 per share on November 10, 2021. Then, on November 15, 2021, Redwire stated it could not timely file its quarterly report for the period ended September 30, 2021. Due to the investigation, "the Company has not been able to finalize its financial statements or its assessment of effectiveness of its disclosure controls and procedures and any impact" on the report. On this news, the Company's stock price fell over 8% over two consecutive trading sessions to close at $10.32 per share on November 16, 2021, harming investors.

If you purchased shares of Redwire Corporation (RDW) between August 11, 2021 and November 14, 2021, you have until February 15, 2022, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Redwire Corporation settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Regencell Bioscience Holdings Limited Class Action Reminder - Robbins LLP Encourages RGC Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

POET Technologies Inc. Class Action Reminder - Robbins LLP Encourages POET Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POET Technologies Inc. (NASDAQ: POET) securities between April 1, 2026 and 8:57 A.M. ET on April 27, 2026. POET Technologies describes itself as a "design and development company offering photonic integrated packaging solutions based on the POET Optical Interposer™, a novel platform that allows the seamless integration of electronic and photoni...

Immutep Limited Class Action Reminder - Robbins LLP Encourages IMMP Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations that Immutep Limited (IMMP) Misled Investors Regarding the Viability and Efficacy of its Drug CandidateOn May 5, 2026, a class action was filed on behalf of all investors who purchased or otherwise acquired Immutep Limited American Depository Receipts (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026. Immutep is an Australian-based biotechnology company focused on developing Lymphocyte Activation Gene-3 (LAG-3) related i...
Back to Newsroom